Document 0655
 DOCN  M9550655
 TI    Tuberculosis in the HIV-infected patient.
 DT    9505
 AU    Waxman S; Gang M; Goldfrank L; Department of Emergency Medicine,
       Bellevue Hospital Center, New; York, New York.
 SO    Emerg Med Clin North Am. 1995 Feb;13(1):179-98. Unique Identifier :
       AIDSLINE MED/95154217
 AB    After decades of decline, tuberculosis has emerged as a global health
       challenge. In the setting of HIV immunocompromise, TB occurs frequently,
       early, and often atypically. New infections can take an accelerated
       course. The usual tests for diagnosing Mycobacterium tuberculosis
       infection are less sensitive when CD4+ counts are low. Increased
       prevalence of treatment failure, drug-resistant strains, and nosocomial
       transmission of multidrug-resistant TB are discussed as are new
       diagnostic tests that will accelerate the time to diagnosis and allow
       better epidemiologic tracking. Early recognition, isolation, appropriate
       therapy, and environmental controls that will protect staff and patients
       from the risk of exposure are also described.
 DE    Antitubercular Agents/ADMINISTRATION & DOSAGE  AIDS-Related
       Opportunistic Infections/*COMPLICATIONS  Demography  Disease Outbreaks
       Disease Transmission, Patient-to-Professional/PREVENTION &  CONTROL
       Drug Therapy, Combination  Emigration and Immigration  Homeless Persons
       Human  HIV Seropositivity/COMPLICATIONS  Infection Control/METHODS
       Mycobacterium tuberculosis/IMMUNOLOGY/PATHOGENICITY  Prisoners
       Tuberculin Test  Tuberculosis/*COMPLICATIONS/DIAGNOSIS/DRUG
       THERAPY/EPIDEMIOLOGY  Tuberculosis, Pulmonary/COMPLICATIONS  United
       States/EPIDEMIOLOGY  JOURNAL ARTICLE  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).